The Artificial Intelligence Act (EU 2024/1689) Whitepaper: Key Obligations, Risks, and Compliance

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

The AI Act sets a global precedent for responsible AI development—balancing innovation with accountability and ensuring AI technologies uphold safety, transparency, and fundamental rights

REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Whitepaper

The Artificial Intelligence Act (Regulation (EU) 2024/1689) is the European Union’s first-ever legislation to comprehensively regulate AI systems. It establishes a risk-based framework to ensure AI technologies are developed and deployed responsibly, balancing innovation with accountability.

This whitepaper provides an essential overview of the AI Act, helping businesses, developers, and public authorities understand the law’s key requirements, who it applies to, and how to prepare for compliance.

Discover the classification of AI systems, specific obligations for high-risk and general-purpose AI models, enforcement mechanisms, penalties, and the upcoming implementation timelines.

Stay ahead of the curve and equip yourself with the knowledge needed to navigate AI regulation confidently.

 

Key Topics Covered

  • What the Artificial Intelligence Act is and why it is needed
  • Who must comply: providers, deployers, importers, distributors, authorised representatives
  • Key definitions: AI systems, systemic risk, general-purpose AI models
  • Risk-based classification of AI systems: Unacceptable, High, Limited, and Minimal risk
  • Detailed obligations for high-risk AI systems, including quality management, transparency, human oversight, and cybersecurity
  • Additional requirements for General-Purpose AI Models with systemic risk
  • Penalties for non-compliance, including fines up to €35 million
  • Practical steps businesses and developers should take now to prepare
  • Important deadlines and the AI Act’s implementation timeline

Learn about AI system risk classifications, compliance obligations, penalties, and timelines and stay ahead of EU AI regulations.

Download your AI Act Compliance Whitepaper

 

Hero Image AI Act WP MedTech

Who this is for

This whitepaper is designed for:

    • AI system developers and providers launching solutions within the EU

    • Organisations deploying AI technologies in operations or services

    • Medical device manufacturers integrating AI into their products

    • Compliance, legal, and regulatory professionals overseeing AI governance

    • Public sector bodies and private organisations using AI in decision-making

    • Anyone seeking to understand and implement the AI Act’s requirements

View our other resources and company news

CPV Header image case study apr 25 Case Study

Implementing a Site-Wide CPV Strategy to Strengthen Process Control

Discover how Rephine developed and implemented a site-wide CPV strategy to improve process control, ensure GMP compliance, and reduce manufacturing variability.
Read More
CPV Header image blog apr 25 Blog

Continued Process Verification (CPV) in GMP Manufacturing

Discover how CPV ensures process control and GMP compliance. Learn key regulatory insights and explore a real case study from Rephine’s validation experts.
Read More
AI Act WP MedTech Header Image (1500 x 844 px) Medical Device

The Artificial Intelligence Act (EU 2024/1689) Whitepaper: Key Obligations, Risks, and Compliance

Learn when medical software qualifies as a medical device under EU MDR & IVDR regulations. Explore classification rules, examples, and compliance tips for manufacturers.
Read More
Medical Software as MD MedTech Guide Header Image (1500 x 844 px) Guide

When Does Medical Software Qualify as a Medical Device? | MDR & IVDR Guide

Learn when medical software qualifies as a medical device under EU MDR & IVDR regulations. Explore classification rules, examples, and compliance tips for manufacturers.
Read More
Dmf case study header Case Study

Navigating DMF Registration in China with Rephine

Explore case study showing the development of a project for a new pharmaceutical manufacturing plant with the objective to fulfill GMP requirements and minimise risks ...
Read More
DMF blog image mar 25 Blog

Breaking into the Chinese Pharmaceutical Market: How to Successfully File a DMF

Learn how to navigate DMF submission in China with Rephine’s expert guidance. From compliance reviews to NMPA approval — streamline your entry into the Chinese ...
Read More
ICH E6 Guide Header Image (1500 x 844 px) CSV

Understanding ICH E6 (R3): Good Clinical Practice and Computerised Systems Validation

The Guide for an Integrated Lifecycle Approach to Analytical Instrument Qualification and System Validation (AIQSV) is an essential resource for pharmaceutical laboratories striving to meet ...
Read More
Intended Purpose MedTech Guide Header Image (1500 x 844 px) Guide

Understanding Intended Purpose in EU MDR & IVDR: Key Implications for Medical Device Manufacturers

Our guide simplifies GSPR compliance, helping medical device companies meet EU safety standards, streamline CE marking, and get market-ready faster.
Read More
qms background Guide

Why eQMS is Important? The Critical Role of eQMS in Modern Quality Management

Navigating the intricate landscape of implementing systems in Life Sciences Quality & R&D requires a strategic approach to the end-to-end
Read More
Contact Us